Free Trial

First Advantage (FA) Competitors

First Advantage logo
$18.60 +0.37 (+2.03%)
As of 01/17/2025 04:00 PM Eastern

FA vs. RTO, CART, ALLE, MEDP, ULS, WPP, GLOB, HQY, STN, and BILI

Should you be buying First Advantage stock or one of its competitors? The main competitors of First Advantage include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), Stantec (STN), and Bilibili (BILI). These companies are all part of the "business services" industry.

First Advantage vs.

First Advantage (NYSE:FA) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Rentokil Initial had 27 more articles in the media than First Advantage. MarketBeat recorded 27 mentions for Rentokil Initial and 0 mentions for First Advantage. First Advantage's average media sentiment score of 1.84 beat Rentokil Initial's score of 0.07 indicating that First Advantage is being referred to more favorably in the media.

Company Overall Sentiment
First Advantage Very Positive
Rentokil Initial Neutral

First Advantage presently has a consensus target price of $53.29, suggesting a potential upside of 186.48%. Rentokil Initial has a consensus target price of $29.00, suggesting a potential upside of 21.77%. Given First Advantage's stronger consensus rating and higher possible upside, analysts plainly believe First Advantage is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Advantage
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.63

Rentokil Initial has higher revenue and earnings than First Advantage. Rentokil Initial is trading at a lower price-to-earnings ratio than First Advantage, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Advantage$763.76M4.20$37.29M$0.03620.00
Rentokil Initial$6.68B1.80$473.93M$1.5415.46

First Advantage has a net margin of 0.65% compared to Rentokil Initial's net margin of 0.00%. First Advantage's return on equity of 13.16% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
First Advantage0.65% 13.16% 7.33%
Rentokil Initial N/A N/A N/A

First Advantage has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

First Advantage received 25 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 56.86% of users gave First Advantage an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
First AdvantageOutperform Votes
29
56.86%
Underperform Votes
22
43.14%
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%

94.9% of First Advantage shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 5.3% of First Advantage shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

First Advantage beats Rentokil Initial on 14 of the 19 factors compared between the two stocks.

Get First Advantage News Delivered to You Automatically

Sign up to receive the latest news and ratings for FA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FA vs. The Competition

MetricFirst AdvantageBusiness services IndustryBusiness SectorNYSE Exchange
Market Cap$3.21B$21.22B$7.47B$19.94B
Dividend YieldN/A2.66%2.33%3.71%
P/E Ratio620.0027.5128.5341.41
Price / Sales4.206.38103.3116.25
Price / Cash9.5433.3829.1419.84
Price / Book2.985.806.195.76
Net Income$37.29M$526.53M$134.52M$993.25M
7 Day Performance6.41%2.98%3.11%3.12%
1 Month Performance0.65%3.83%4.99%4.75%
1 Year Performance13.48%10.38%24.01%18.83%

First Advantage Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FA
First Advantage
3.0969 of 5 stars
$18.60
+2.0%
$53.29
+186.5%
+13.5%$3.21B$763.76M620.005,000Positive News
RTO
Rentokil Initial
3.1414 of 5 stars
$23.88
+1.9%
$29.00
+21.4%
-8.8%$12.06B$5.41B16.9462,900
CART
Maplebear
4.1398 of 5 stars
$44.29
+0.1%
$47.63
+7.5%
+78.1%$11.38B$3.30B29.723,380
ALLE
Allegion
4.0193 of 5 stars
$127.91
+1.3%
$140.83
+10.1%
+9.4%$11.12B$3.72B19.6511,000Short Interest ↑
MEDP
Medpace
4.5427 of 5 stars
$351.00
+0.0%
$380.56
+8.4%
+14.1%$10.91B$2.07B30.745,900News Coverage
ULS
UL Solutions
1.6041 of 5 stars
$49.96
+1.3%
$49.00
-1.9%
N/A$10.00B$2.82B0.0015,233
WPP
WPP
1.3266 of 5 stars
$43.94
-0.1%
N/A-2.0%$9.48B$14.85B7.47114,732
GLOB
Globant
3.9327 of 5 stars
$205.50
-1.0%
$230.44
+12.1%
-7.8%$8.85B$2.35B53.6629,150Short Interest ↑
Positive News
HQY
HealthEquity
2.9158 of 5 stars
$101.15
+0.8%
$110.71
+9.5%
+40.0%$8.77B$1.15B92.803,150
STN
Stantec
3.7413 of 5 stars
$76.47
+0.5%
N/A-3.5%$8.72B$7.15B34.7628,000Positive News
BILI
Bilibili
2.7078 of 5 stars
$16.07
+0.6%
$19.69
+22.5%
+85.7%$6.66B$25.45B-17.478,801

Related Companies and Tools


This page (NYSE:FA) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners